Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital of Schleswig-Holstein, Germany.
Migraine and Headache Clinic Königstein, Königstein im Taunus, Germany.
Cephalalgia. 2020 Jul;40(8):788-796. doi: 10.1177/0333102420907593. Epub 2020 Feb 17.
To investigate whether the self-treatment of migraine among neurologists and pain specialists corresponds to national medical guidelines and treatment of patients.
An email cross-sectional survey was sent to members of the German Society for Neurology, German Pain Society and German Migraine and Headache Society containing questions on demographics, professional experience and specialization and - in case participants suffered from migraine - questions about their migraine and its treatment.
175/418 (41.9%) participants suffered from migraine (m: 29.3%; f: 55.2%, 45.9 ± 10.7 years). For acute migraine attacks, 96.6 % of them use a first-line treatment according to the medical guidelines. Seventeen (9.7%) are currently taking a migraine prophylaxis, 52.9% of these use a recommended first-line prophylaxis. In all, 21.7% are not taking a prophylactic treatment despite an indication (based on number of monthly migraine days) for it, due to fear of side-effects, low intensity of migraine attacks and a sufficient effect of acute medication. This group of participants was younger, less experienced and specialized and was mainly employed (vs. self-employed) compared to those taking a prophylaxis. A total of 96.6% reported treating their patients in line with current guidelines; 14.3% would treat themselves differently when they were their own patients.
The self-treatment of acute migraine attacks for the most part complies with the guidelines but, regarding the indication for a prophylaxis, a more divergent treatment approach was observed among younger, less experienced physicians. For the majority of physicians there is no difference between self-treatment and treatment of migraine patients.
调查神经科医生和疼痛专家对偏头痛的自我治疗是否符合国家医学指南和对患者的治疗。
向德国神经病学会、德国疼痛学会和德国偏头痛和头痛学会的成员发送了一份电子邮件横断面调查，其中包含人口统计学、专业经验和专业知识的问题，如果参与者患有偏头痛，则还包含有关偏头痛及其治疗的问题。
175/418（41.9%）名参与者患有偏头痛（m：29.3%；f：55.2%，45.9±10.7 岁）。对于急性偏头痛发作，他们中的 96.6%使用了符合医学指南的一线治疗方法。有 17 人（9.7%）目前正在服用偏头痛预防药物，其中 52.9%的人使用了推荐的一线预防药物。尽管根据每月偏头痛天数存在预防治疗的指征，但由于担心副作用、偏头痛发作的强度较低以及急性药物的效果足够，总共有 21.7%的人没有接受预防性治疗。这组参与者年龄较小，经验较少，专业化程度较低，主要受雇（与自雇相比），而服用预防药物的人则更多。共有 96.6%的人报告说他们的患者的治疗符合当前指南；14.3%的人在自己是患者时会采取不同的治疗方法。
急性偏头痛发作的自我治疗在很大程度上符合指南，但在预防治疗的指征方面，年轻、经验较少的医生的治疗方法更为多样化。对于大多数医生来说，自我治疗和治疗偏头痛患者之间没有区别。
